Stoke Therapeutics Inc buy Chardan Capital
Start price
18.03.26
/
50%
€26.60
Target price
18.03.27
€30.34
Performance (%)
6.32%
Price
10.08.26
€27.86
Summary
This prediction is currently active. With a performance of 6.32%, the BUY prediction by Chardan_Capital for Stoke Therapeutics Inc is trending in the right direction. This prediction currently runs until 18.03.27. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 12.520% | 12.520% |
| iShares Core DAX® | 1.001% | 4.831% |
| iShares Nasdaq 100 | 2.702% | -1.720% |
| iShares Nikkei 225® | 3.519% | -3.506% |
| iShares S&P 500 | 1.766% | 1.273% |
Comments by Chardan_Capital for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (STOK) had its "buy" rating reaffirmed by Chardan Capital. They now have a $35.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€25.52
04.08.26
04.08.26
€30.41
04.08.27
04.08.27
9.17%
10.08.26
10.08.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€25.80
05.01.26
05.01.26
€29.93
05.01.27
05.01.27
9.61%
10.08.26
10.08.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
13.08.25
13.08.25
€20.55
13.08.26
13.08.26
104.93%
10.08.26
10.08.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.95
19.02.25
19.02.25
€23.00
19.02.26
19.02.26
221.79%
20.02.26
20.02.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€10.70
20.12.24
20.12.24
€23.06
20.12.25
20.12.25
152.34%
21.12.25
21.12.25